Showing results (951-960 of 3,591) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|February 15, 2012
Detection of specific antibodies to HCV-ARF/CORE+1 protein in patients treated with pegylated interferon plus ribavirinT Karamitros, A Kakkanas, A Katsoulidou, et al.Journal of Viral Hepatitis|April 14, 2012
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment responseP J Clark, A J Thompson, M Zhu, et al.Journal of Viral Hepatitis|April 14, 2012
Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagationY S Lim, K S Shin, S H Oh, et al.Journal of Viral Hepatitis|April 14, 2012
End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infectionF M Aslinia, S K Wasan, A L Mindikoglu, et al.Journal of Viral Hepatitis|January 12, 2012
Optimal treatment duration for patients with HCV genotype 1 infectionP FerenciJournal of Viral Hepatitis|January 14, 2012
Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virusC Xiao, B Qin, L Chen, et al.Journal of Viral Hepatitis|January 14, 2012
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral responseA Craxi, S Koutsounas, P Ogurtsov, et al.Journal of Viral Hepatitis|January 14, 2012
Transient elastography for predicting clinical outcomes in patients with chronic liver diseaseD A Klibansky, S H Mehta, M Curry, et al.Journal of Viral Hepatitis|January 14, 2012
Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature reviewT Kawaguchi, T Ide, M Itou, et al.Journal of Viral Hepatitis|January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activityL Bachmetov, M Gal-Tanamy, A Shapira, et al.Pageof 360